Publication

2026


  • A. Callahan, R. Puterbaugh, T. Ro, X. Zhang, X. Su, A. Salomon (2026). “Phosphoproteomic analysis of successive Jurkat CD19-CAR generations reveals TCRζ-driven signalling”. Cellular Signalling, 138:112204.
  • A. Callahan, S.S. Trychanh, T. Ro, A. Mojumdar, A.R. Salomon. (2026). “Phosphotyrosine proteomics reveals novel Zap70 and Itk pathway targets downstream of TCR and CAR in Jurkat T cells.” Sci. Rep., in press. doi:10.1038/s41598-026-47234-x.

2025


  • A. Callahan, A. Mojumdar, A.R. Salomon, N.A. DaSilva. (2025). “Evaluating first-pass, high protein capacity desalting techniques for phosphoproteomics applications.” bioRxiv, 2025.06.03.657744. doi:10.1101/2025.06.03.657744.

  • A. Callahan, X. Zhang, A. Wang, A. Mojumdar, L. Zeng, X. Su*, A. Salomon*. (2025). “CSF1R-CAR T cells induce CSF1R signaling and can promote target cell proliferation.” Science Signaling. 18: eadv4112.

  • A. Callahan, A. Mojumdar, M. Hu, A. Wang, A. Griffith, N. Huang, X. Chua, N. Mroz, R. Puterbaugh, S. Reilly, A. Salomon (2025). “The phosphatases TCPTP, PTPN22, and SHP1 play unique roles in T cell phosphotyrosine maintenance and feedback regulation of the TCR.” Sci. Rep, 15:27747.
  • J. Wan, P. Morse, M. Zurek 1,2, A. Turner, A. Vaishnav, A. Salomon, B. Edwards, T. Arroum, and M. Hüttemann (2025). “Tyrosine 67 Phosphorylation Controls Respiration and Limits the Apoptotic Functions of Cytochrome c”. Cells. 14(3): 951.

2024


  • A. Callahan, X. Chua, A. Griffith, T. Hildebrandt, G. Fu, M. Hu, R. Wen, A. Salomon* (2024). “Deep phosphotyrosine characterization of primary murine T cells using broad spectrum optimization of selective triggering”. Proteomics. 24(23-24):e2400106.

2023


  • G. Fu, Y. Zheng, G. Xin, Z. Wang, K. Bunting, W. Cui, A. Salomon, R. Wen (2023). “Gab3 Plays an Essential Role in CD8 + T-Cell Expansion through Regulating IL-2-Mediated Activation of PI3K/AKT/mTOR and Erk/FoxO Pathways.” Blood. 142:3931.

2022


  • A. Griffith, K. Callahan, N King, Q. Xiao, X. Su, A. Salomon* (2022). “SILAC phosphoproteomics reveals unique signaling circuits in CAR-T cells and the inhibition of B cell-activating phosphorylation in target cells.” J Proteome Res. 21(2):395-409.

2021


  • X. Chua, T. Aballo, W. Elnemer, M. Tran, A. Salomon* (2021). “Quantitative interactomics of Lck-TurboID in living human T cells unveils T cell receptor stimulation-induced proximal Lck interactors.” J Proteome Res. 20(1):715-726.
  • X. Chua, A. Salomon* (2021). “Ovalbumin antigen-specific activation of T cell receptor closely resembles soluble antibody stimulation as revealed by BOOST phosphotyrosine proteomics.” J. Proteome Res. 20(6):3330-3344.

2020


  • X. Chua, T. Mensah, T. Aballo, S. Mackintosh, R. Edmondson, A. Salomon (2020). “Tandem mass tag approach utilizing pervanadate boost channels delivers deeper quantitative characterization of the tyrosine phosphoproteome.” Molecular and Cellular Proteomics, 19(4):730-43.

2019


  • M. Curtis, H. Kenny, B. Ashcroft, A. Mukherjee, A. Johnson, Y. Zhang, Y. Helou, R. Batlle, X. Liu, N. Gutierrez, X. Gao, S. Yamada, R. Lastra, A. Montag, N. Ahsan, J. Locasale, A. Salomon, A. Nebreda, E. Lengyel (2019). “Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis.” Cell Metabolism, 29:141-155.
  • N. Ahsan, J. Boylan, A. Salomon, J. Sanders, P. Gruppuso (2019). “Quantitative proteomics and phosphoproteomics from formalin-fixed, paraffin-embedded tissue samples.” Methods Mol. Biol. In press.

2018


2017


2016


2015


2014


2013


2012


2011


2010


2009


2008


2007


2006


2005


2004


2003


2002


  • A. Brock, D. Horn, C. Shaw, E. Peters, C. Ericson, Q. Phung, S. Ficarro, A. Salomon (2002). “Automated Liquid Chromatography MALDI FT-ICR MS Platform for Proteomics: Automated High Performance Mass Spectrometry and Data Analysis” Am. Pharma. Rev., 5(4): 94-99.
  • E. Peters, A. Brock, Q. Phung, J. Fitchett, D. Horn, C. Ericson, S. Ficarro, A. Salomon (2002). “Automated Liquid Chromatography MALDI FT-ICR MS Platform for Proteomics: Rationale for an Off-Line Approach and Optimized Implementation” Am. Pharma. Rev., 5(3): 72-81.
  • E. Peters, A. Brock, D. Horn, Q. Phung, C. Ericson, A. Salomon, S. Ficarro, L. Brill (2002). “An automated LC-MALDI FT-ICR MS platform for high-throughput proteomics.” LCGC Europe, 15(7): 423-8.
  • J. Pennington, H. Williams, A. Salomon, G. Sulikowski (2002). “Toward a stable apoptolidin derivative: Identification of isoapoptolidin and selective deglycosylation of apoptolidin.Organic Letters, 4(22): 3823-3825.

2001


2000


1997


  • H. Shao, K. Marcinowski, E. Clancy, A. Salomon and M. Zagorski (1997). “The Solution Structures of the ß-Amyloid Peptide Provide a Molecular Approach for the Treatment of Alzheimer’s Disease.” In K. Iqbal, B. Winblad, T. Nishimura, M. Takeda and H. M. Wisniewski (eds), Alzheimer’s Disease: Biology, Diagnosis and Therapeutics New York, John Wiley & Sons, pp 729-739.

1996


Dr. Arthur Salomon @ Brown University uses Accessibility Checker to monitor our website's accessibility.

HTML Snippets Powered By : XYZScripts.com